Clinical and genetic characterisation of dystrophin-deficient muscular dystrophy in a family of Miniature Poodle dogs

PLoS One. 2018 Feb 23;13(2):e0193372. doi: 10.1371/journal.pone.0193372. eCollection 2018.

Abstract

Four full-sibling intact male Miniature Poodles were evaluated at 4-19 months of age. One was clinically normal and three were affected. All affected dogs were reluctant to exercise and had generalised muscle atrophy, a stiff gait and a markedly elevated serum creatine kinase activity. Two affected dogs also showed poor development, learning difficulties and episodes of abnormal behaviour. In these two dogs, investigations into forebrain structural and metabolic diseases were unremarkable; electromyography demonstrated fibrillation potentials and complex repetitive discharges in the infraspinatus, supraspinatus and epaxial muscles. Histopathological, immunohistochemical and immunoblotting analyses of muscle biopsies were consistent with dystrophin-deficient muscular dystrophy. DNA samples were obtained from all four full-sibling male Poodles, a healthy female littermate and the dam, which was clinically normal. Whole genome sequencing of one affected dog revealed a >5 Mb deletion on the X chromosome, encompassing the entire DMD gene. The exact deletion breakpoints could not be experimentally ascertained, but we confirmed that this region was deleted in all affected males, but not in the unaffected dogs. Quantitative polymerase chain reaction confirmed all three affected males were hemizygous for the mutant X chromosome, while the wildtype chromosome was observed in the unaffected male littermate. The female littermate and the dam were both heterozygous for the mutant chromosome. Forty-four Miniature Poodles from the general population were screened for the mutation and were homozygous for the wildtype chromosome. The finding represents a naturally-occurring mutation causing dystrophin-deficient muscular dystrophy in the dog.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dog Diseases / genetics*
  • Dog Diseases / pathology
  • Dog Diseases / physiopathology*
  • Dog Diseases / therapy
  • Dogs
  • Dystrophin / deficiency*
  • Dystrophin / genetics*
  • Genes, Recessive
  • Genes, X-Linked
  • Genetic Diseases, X-Linked / genetics
  • Genetic Diseases, X-Linked / pathology
  • Genetic Diseases, X-Linked / physiopathology
  • Genetic Diseases, X-Linked / therapy
  • Male
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Muscular Dystrophy, Animal / genetics*
  • Muscular Dystrophy, Animal / pathology
  • Muscular Dystrophy, Animal / physiopathology*
  • Muscular Dystrophy, Animal / therapy
  • Pedigree
  • Siblings

Substances

  • Dystrophin

Grants and funding

The work was supported by the Animal Health Trust and the Kennel Club Charitable Trust. The funders provided support in the form of salaries for authors LS, EB, AdS, AS and LDR (Animal Health Trust) and LMB (Kennel Club Charitable Trust). The Kennel Club Genetics Centre at the Animal Health Trust is maintained by funding from the Kennel Club Charitable Trust (https://kccharitabletrust.org.uk/). One of the authors is currently employed by a commercial company, Dick White Referrals, but this affiliation did not play a role in the study as the author (AdS) was based at the Animal Health Trust at the time of their contribution to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.